Literature DB >> 7935543

Creatine treatment in MELAS.

L Hagenfeldt, U von Döbeln, G Solders, L Kaijser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935543

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  8 in total

1.  Melas syndrome.

Authors:  S K Singh; D Sarin; J M Puliyel; R Srivastav; R Gupta; N Kumar; A Mathews
Journal:  Indian J Pediatr       Date:  1999 Jul-Aug       Impact factor: 1.967

Review 2.  Adverse effects of creatine supplementation: fact or fiction?

Authors:  J R Poortmans; M Francaux
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 3.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics.

Authors:  E O'Gorman; T Piendl; M Müller; D Brdiczka; T Wallimann
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 5.  Creatine for treating muscle disorders.

Authors:  Rudolf A Kley; Mark A Tarnopolsky; Matthias Vorgerd
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

6.  Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

Authors:  R T Matthews; L Yang; B G Jenkins; R J Ferrante; B R Rosen; R Kaddurah-Daouk; M F Beal
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

Review 7.  Pharmacokinetics of the dietary supplement creatine.

Authors:  Adam M Persky; Gayle A Brazeau; Günther Hochhaus
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle.

Authors:  M L Guerrero-Ontiveros; T Wallimann
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.